Quality Improvement Project - Evaluation of Current Standard of Care for Feeding Practices in the NICU
Sponsored by Baylor College of Medicine
About this trial
Last updated 2 months ago
Study ID
H-26923
Status
Completed
Type
Observational
Placebo
No
Accepting
1+ Years
All Sexes
Trial Timing
Ended 3 months ago
What is this trial about?
Human milk is associated with substantial benefits to infants' health and development, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk as an alternative to cow milk in these infants has risen dramatically in the past year. However, there have been recent reports of hyperphosphatemia and hyponatremia associated with the consumption of donor human milk products. These electrolyte imbalances can lead to concerning symptoms, including headache, nausea, vomiting, altered mental status, coma, seizures, or heart failure. It is important to recognize and appropriately treat these electrolyte disturbances associated with donor human milk to avoid potential nutritional problems.
What are the participation requirements?
Inclusion Criteria
* Premature infants (<37 weeks gestation) with a birth weight less than or equal to 1250 grams.
Exclusion Criteria
* Infants with a birth weight greater than 1250 grams
* Infants transferred from an outside hospital to TCH at greater than 21 days of age
* Infants who do not achieve any enteral feeds by 4 weeks of age
* Infants with major congenital anomalies
